Robinson, D, Wu, H, Munne, RA, Ashtari, M, Alvir, JM, Lerner, G, et al. Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry
1995; 52: 393–8.
Aylward, EH, Harris, GJ, Hoehn-Saric, R, Barta, PE, Machlin, SR, Pearlson, GD. Normal caudate nucleus in obsessive-compulsive disorder assessed by quantitative neuroimaging. Arch Gen Psychiatry
1996; 53: 577–84.
Scarone, S, Colombo, C, Livian, S, Abbruzzese, M, Ronchi, P, Locatelli, M, et al. Increased right caudate nucleus size in obsessive-compulsive disorder: detection with magnetic resonance imaging. Psychiatry Res
1992; 45: 115–21.
Ashburner, J, Friston, KJ. Voxel-based morphometry-the methods. Neuroimage
2000; 11: 805–21.
Ashburner, J, Friston, KJ. Why voxel-based morphometry should be used. Neuroimage
2001; 14: 1238–43.
Mechelli, A, Price, CJ, Friston, KJ, Ashburner, J. Voxel-based morphometry of the human brain: methods and applications. Curr Med Imag Rev
2005; 1: 105–13.
Mataix-Cols, D, Pertusa, A, Leckman, JF. Issues for DSM-V: how should obsessive-compulsive and related disorders be classified?
Am J Psychiatry
2007; 164: 1313–4.
Cecconi, JP, Lopes, AC, Duran, FL, Santos, LC, Hoexter, MQ, Gentil, AF, et al. Gamma ventral capsulotomy for treatment of resistant obsessive-compulsive disorder: a structural MRI pilot prospective study. Neurosci Lett
2008; 447: 138–42.
Cardoner, N, Soriano-Mas, C, Pujol, J, Alonso, P, Harrison, BJ, Deus, J, et al. Brain structural correlates of depressive comorbidity in obsessive-compulsive disorder. Neuroimage
2007; 38: 413–21.
Soriano-Mas, C, Pujol, J, Alonso, P, Cardoner, N, Menchon, JM, Harrison, BJ, et al. Identifying patients with obsessive-compulsive disorder using whole-brain anatomy. Neuroimage
2007; 35: 1028–37.
Stroup, DF, Berlin, JA, Morton, SC, Olkin, I, Williamson, GD, Rennie, D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA
2000; 283: 2008–12.
Turkeltaub, PE, Eden, GF, Jones, KM, Zeffiro, TA. Meta-analysis of the functional neuroanatomy of single-word reading: method and validation. Neuroimage
2002; 16: 765–80.
Wager, TD, Lindquist, M, Kaplan, L. Meta-analysis of functional neuroimaging data: current and future directions. Soc Cogn Affect Neurosci
2007; 2: 150–8.
Lancaster, JL, Tordesillas-Gutierrez, D, Martinez, M, Salinas, F, Evans, A, Zilles, K, et al. Bias between MNI and Talairach coordinates analyzed using the ICBM-152 brain template. Hum Brain Mapp
2007; 28: 1194–205.
Lancaster, JL, Woldorff, MG, Parsons, LM, Liotti, M, Freitas, CS, Rainey, L, et al. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp
2000; 10: 120–31.
Salimi-Khorshidi, G, Smith, SM, Keltner, JR, Wager, TD, Nichols, TE. Meta-analysis of neuroimaging data: a comparison of image-based and coordinate-based pooling of studies. Neuroimage
2008; 45: 810–23.
Menzies, L, Chamberlain, SR, Laird, AR, Thelen, SM, Sahakian, BJ, Bullmore, ET. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev
2008; 32: 525–49.
Genovese, CR, Lazar, NA, Nichols, T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage
2002; 15: 870–8.
Carmona, S, Bassas, N, Rovira, M, Gispert, JD, Soliva, JC, Prado, M, et al. Pediatric OCD structural brain deficits in conflict monitoring circuits: a voxel-based morphometry study. Neurosci Lett
2007; 421: 218–23.
Christian, CJ, Lencz, T, Robinson, DG, Burdick, KE, Ashtari, M, Malhotra, AK, et al. Gray matter structural alterations in obsessive-compulsive disorder: relationship to neuropsychological functions. Psychiatry Res
2008; 164: 123–31.
Gilbert, AR, Mataix-Cols, D, Almeida, JR, Lawrence, N, Nutche, J, Diwadkar, V, et al. Brain structure and symptom dimension relationships in obsessive-compulsive disorder: a voxel-based morphometry study. J Affect Disord
2008; 109: 117–26.
Gilbert, AR, Keshavan, MS, Diwadkar, V, Nutche, J, Macmaster, F, Easter, PC, et al. Gray matter differences between pediatric obsessive-compulsive disorder patients and high-risk siblings: a preliminary voxel-based morphometry study. Neurosci Lett
2008; 435: 45–50.
Pujol, J, Soriano-Mas, C, Alonso, P, Cardoner, N, Menchon, JM, Deus, J, et al. Mapping structural brain alterations in obsessive-compulsive disorder. Arch Gen Psychiatry
2004; 61: 720–30.
Riffkin, J, Yucel, M, Maruff, P, Wood, SJ, Soulsby, B, Olver, J, et al. A manual and automated MRI study of anterior cingulate and orbito-frontal cortices, and caudate nucleus in obsessive-compulsive disorder: comparison with healthy controls and patients with schizophrenia. Psychiatry Res
2005; 138: 99–113.
Valente, AA Jr, Miguel, EC, Castro, CC, Amaro, E Jr, Duran, FL, Buchpiguel, CA, et al. Regional gray matter abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study. Biol Psychiatry
2005; 58: 479–87.
van den Heuvel, OA, Remijnse, PL, Mataix-Cols, D, Vrenken, H, Groenewegen, HJ, Uylings, HB, et al. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain
2009; 132: 853–68.
Goodman, WK, Price, LH, Rasmussen, SA, Mazure, C, Fleischmann, RL, Hill, CL, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry
1989; 46: 1006–11.
Kim, JJ, Lee, MC, Kim, J, Kim, IY, Kim, SI, Han, MH, et al. Grey matter abnormalities in obsessive–compulsive disorder. Statistical parametric mapping of segmented magnetic resonance images. Br J Psychiatry
2001; 179: 330–4.
Szeszko, PR, Christian, C, Macmaster, F, Lencz, T, Mirza, Y, Taormina, SP, et al. Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study. Am J Psychiatry
2008; 165: 1299–307.
Yoo, SY, Roh, MS, Choi, JS, Kang, DH, Ha, TH, Lee, JM, et al. Voxel-based morphometry study of gray matter abnormalities in obsessive-compulsive disorder. J Korean Med Sci
2008; 23: 24–30.
Rapoport, JL, Wise, SP. Obsessive-compulsive disorder: evidence for basal ganglia dysfunction. Psychopharmacol Bull
1988; 24: 380–4.
Baxter, LR Jr, Saxena, S, Brody, AL, Ackermann, RF, Colgan, M, Schwartz, JM, et al. Brain mediation of obsessive-compulsive disorder symptoms: evidence from functional brain imaging studies in the human and nonhuman primate. Semin Clin Neuropsychiatry
1996; 1: 32–47.
Saxena, S, Brody, AL, Schwartz, JM, Baxter, LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry
1998; 173 (suppl 35): 26–37.
Mataix-Cols, D, van den Heuvel, OA. Common and distinct neural correlates of obsessive-compulsive and related disorders. Psychiatr Clin North Am
2006; 29: 391–410, .
Swedo, SE, Schapiro, MB, Grady, CL, Cheslow, DL, Leonard, HL, Kumar, A, et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry
1989; 46: 518–23.
Perani, D, Colombo, C, Bressi, S, Bonfanti, A, Grassi, F, Scarone, S, et al. [18F]FDG PET study in obsessive–compulsive disorder. A clinical/metabolic correlation study after treatment. Br J Psychiatry
1995; 166: 244–50.
Rauch, SL, Jenike, MA, Alpert, NM, Baer, L, Breiter, HC, Savage, CR, et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry
1994; 51: 62–70.
Breiter, HC, Rauch, SL, Kwong, KK, Baker, JR, Weisskoff, RM, Kennedy, DN, et al. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry
1996; 53: 595–606.
Mataix-Cols, D, Wooderson, S, Lawrence, N, Brammer, MJ, Speckens, A, Phillips, ML. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry
2004; 61: 564–76.
Fitzgerald, KD, Welsh, RC, Gehring, WJ, Abelson, JL, Himle, JA, Liberzon, I, et al. Error-related hyperactivity of the anterior cingulate cortex in obsessive-compulsive disorder. Biol Psychiatry
2005; 57: 287–94.
Ursu, S, Stenger, VA, Shear, MK, Jones, MR, Carter, CS. Overactive action monitoring in obsessive-compulsive disorder: evidence from functional magnetic resonance imaging. Psychol Sci
2003; 14: 347–53.
Yucel, M, Harrison, BJ, Wood, SJ, Fornito, A, Wellard, RM, Pujol, J, et al. Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder. Arch Gen Psychiatry
2007; 64: 946–55.
Maltby, N, Tolin, DF, Worhunsky, P, O'Keefe, TM, Kiehl, KA. Dysfunctional action monitoring hyperactivates frontal-striatal circuits in obsessive-compulsive disorder: an event-related fMRI study. Neuroimage
2005; 24: 495–503.
Chamberlain, SR, Blackwell, AD, Fineberg, NA, Robbins, TW, Sahakian, BJ. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev
2005; 29: 399–419.
Rauch, SL, Dougherty, DD, Malone, D, Rezai, A, Friehs, G, Fischman, AJ, et al. A functional neuroimaging investigation of deep brain stimulation in patients with obsessive-compulsive disorder. J Neurosurg
2006; 104: 558–65.
Greenberg, BD, Gabriels, LA, Malone, DA Jr, Rezai, AR, Friehs, GM, Okun, MS, et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry
Liu, K, Zhang, H, Liu, C, Guan, Y, Lang, L, Cheng, Y, et al. Stereotactic treatment of refractory obsessive compulsive disorder by bilateral capsulotomy with 3 years follow-up. J Clin Neurosci
2008; 15: 622–9.
Nuttin, BJ, Gabriels, LA, Cosyns, PR, Meyerson, BA, Andreewitch, S, Sunaert, SG, et al. Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder. Neurosurgery
2003; 52: 1263–72.
Dougherty, DD, Baer, L, Cosgrove, GR, Cassem, EH, Price, BH, Nierenberg, AA, et al. Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder. Am J Psychiatry
2002; 159: 269–75.
Greenspan, JD, Coghill, RC, Gilron, I, Sarlani, E, Veldhuijzen, DS, Lenz, FA. Quantitative somatic sensory testing and functional imaging of the response to painful stimuli before and after cingulotomy for obsessive-compulsive disorder (OCD). Eur J Pain
2008; 12: 990–9.
Kim, CH, Chang, JW, Koo, MS, Kim, JW, Suh, HS, Park, IH, et al. Anterior cingulotomy for refractory obsessive-compulsive disorder. Acta Psychiatr Scand
2003; 107: 283–90.
Spangler, WJ, Cosgrove, GR, Ballantine, HT Jr, Cassem, EH, Rauch, SL, Nierenberg, A, et al. Magnetic resonance image-guided stereotactic cingulotomy for intractable psychiatric disease. Neurosurgery
1996; 38: 1071–6.
Ballantine, HT Jr, Bouckoms, AJ, Thomas, EK, Giriunas, IE. Treatment of psychiatric illness by stereotactic cingulotomy. Biol Psychiatry
1987; 22: 807–19.
Kim, MC, Lee, TK, Choi, CR. Review of long-term results of stereotactic psychosurgery. Neurol Med Chir (Tokyo)
2002; 42: 365–71.
Alexander, GE, Crutcher, MD, DeLong, MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, ‘prefrontal’ and ‘limbic’ functions. Prog Brain Res
1990; 85: 119–46.
Kunishio, K, Haber, SN. Primate cingulostriatal projection: limbic striatal versus sensorimotor striatal input. J Comp Neurol
1994; 350: 337–56.
Rauch, SL, Kim, H, Makris, N, Cosgrove, GR, Cassem, EH, Savage, CR, et al. Volume reduction in the caudate nucleus following stereotactic placement of lesions in the anterior cingulate cortex in humans: a morphometric magnetic resonance imaging study. J Neurosurg
2000; 93: 1019–25.
Menzies, L, Achard, S, Chamberlain, SR, Fineberg, N, Chen, CH, del Campo, N, et al. Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain
2007; 130: 3223–6.
Menzies, L, Williams, GB, Chamberlain, SR, Ooi, C, Fineberg, N, Suckling, J, et al. White matter abnormalities in patients with obsessive-compulsive disorder and their first-degree relatives. Am J Psychiatry
2008; 165: 1308–15.
Gilbert, AR, Moore, GJ, Keshavan, MS, Paulson, LA, Narula, V, MacMaster, FP, et al. Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Arch Gen Psychiatry
2000; 57: 449–56.
Rosenberg, DR, MacMaster, FP, Keshavan, MS, Fitzgerald, KD, Stewart, CM, Moore, GJ. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry
2000; 39: 1096–103.
Mataix-Cols, D, Rosario-Campos, MC, Leckman, JF. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry
2005; 162: 228–38.
Saxena, S, Brody, AL, Maidment, KM, Smith, EC, Zohrabi, N, Katz, E, et al. Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry
2004; 161: 1038–48.
An, SK, Mataix-Cols, D, Lawrence, NS, Wooderson, S, Giampietro, V, Speckens, A, et al. To discard or not to discard: the neural basis of hoarding symptoms in obsessive-compulsive disorder. Mol Psychiatry
2008; 14: 318–31.